This document provides an overview of public funding opportunities for research and development (R&D) projects from the European Union and other international sources. It discusses major EU programmes like Horizon 2020 and Eureka, as well as country-specific opportunities from Poland, Israel, and Norway. The presentation aims to help attendees understand available funding mechanisms, eligibility requirements, typical project timelines and budgets. It also provides tips on developing competitive funding applications and an upcoming call calendar.

1. Publ fundingopporunit forR a
ic t ies &D nd
innov t proj s
aion ect
Jan Kaczmarek, CSO, Partner – EXEQ

2. a us
bout
• grant consultancy
• specilized in R&D and innovation programmes
• 7 years in business
• team of 10 consultants
• domain experts (computer science,
telecommunications, biotech) from recognised R&D
institutes
• ~20 projects annually
• success rate: ~3 x average retention rate
Publ funding forR&D&I
ic 2

3. a me
bout
• Co-funder of EXEQ
• R&D project manager, proposal writer, consortia
matchmaker (since 2004)
• (co)authored over 50 proposals
• ~ 10K working hours
• Economics and IT background
• Project evaluator (incl. 7th Framework Programme)
Publ funding forR&D&I
ic 3

4. cust s
omer
Publ funding forR&D&I
ic 4

5. EU-ev progr mmes
l el a
Publ funding forR&D&I
ic 5

6. progr mmes in Pol nd
a a
R&D project for
1.4 3.3.2 5.4.1 6.1 2.1.1 6.1
companies
8.1 8.2
Technological Loans
Publ funding forR&D&I
ic 6

7. agenda
• introduction
• overview of funding opportunities
• profiles of selected programmes
• call calendar excerpt
• Q&A
Publ funding forR&D&I
ic 7

8. moto
t
„People say you have to rob your first 1
million, I got mine from a public grant”
- Mateusz Flis, founder of Ives System
Publ funding forR&D&I
ic 8

9. ov v
er iew
• 7th Framework Programme --> Horizon 2020
• Eureka
• Eurostars
• ERASME
• EEA Grants
• Israeli Industrial bilateral R&D Cooperation
Framework
Publ funding forR&D&I
ic 9

10. 7t Fr mew k Progr mme
h a or a
Planned for the years 2007-2013
--> Horizon 2020 (in 587 days)
Total budget of € 50 billion
•based on calls for proposals
•peer reviewed
•highly competitive
•medium to large cross-EU consortia
•considerable budgets (EUR ~2-20M)
Publ funding forR&D&I
ic 10

11. w ca a y?
ho n ppl
open to a wide range of organisations, including:
• research groups at universities or research institutes
• small or medium-sized enterprises (SMEs)
• public or governmental administration (local, regional
or national)
• international organisations
• civil society organisations
from:
EU member countries & associate countries (EEA,
candidate countries, Israel, Switzerland)
Publ funding forR&D&I
ic 11

12. FPSt uct
r ure
5 major building blocks:
• Ideas
• People
• Capacities
• Nuclear Research
• Cooperation (the core of FP7, representing two thirds
of the overall budget)
Ten thematic areas including:
• HEALTH
• FOOD, AGRICULTURE AND FISHERIES,
BIOTECHNOLOGY
Publ funding forR&D&I
ic 12

13. ba FPr es
sic ul
Participation Duration Max budget Funding rate
R&D activities up
On average: EU to 75%
Average: 5 - 16 36 months contribution €2M Demonstration
50%
Other up to 100%
Publ funding forR&D&I
ic 13

14. cal
ls
• Health - 20 closed calls
• Food, Agriculture and Fisheries, and Biotechnology –
21 closed calls
• Work Programmes for 2013 expected in mid-July
2
2012
http://ec.europa.eu/research/participants/portal/page/cooper
• Orientation paper now online!, via the above address
Publ funding forR&D&I
ic 14

15. t in t or aion pa
opics he ient t per
BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES
FOR HUMAN HEALTH
• 1.1 High-throughput research
• 1.2 Detection, diagnosis and monitoring
• 1.3 Suitability, safety, efficacy of therapies
• 1.4 Innovative therapeutic approaches and interventions
TRANSLATING RESEARCH FOR HUMAN HEALTH
• 2.1 Integrating biological data and processes: large-scale data
gathering, systems biology
• 2.2 Research on the brain and related diseases, human development
and ageing
• 2.3 Translational research in major infectious diseases: to confront
major threats to public health
• 2.3.1 Anti-microbial drug resistance
2.3.2 HIV/AIDS, malaria and tuberculosis
2.3.3 Potentially new and re-emerging epidemics
2.3.4 Neglected infectious diseases
Publ funding forR&D&I
ic 15

16. t in t or aion pa
opics he ient t per
• 2.4 Translational research in other major diseases
2.4.1 Cancer
2.4.2 Cardiovascular diseases
2.4.3 Diabetes and obesity
2.4.4 Rare diseases
2.4.5 Other chronic diseases
• 3.1 Translating the results of clinical research outcome
into clinical practice
• 3.2 Quality, efficiency and solidarity of healthcare
systems
• 3.3 Health promotion and prevention
Publ funding forR&D&I
ic 16

17. EUREKA
• International network of 40 partners
• 200 projects yearly
• Any technological area
MAIN RULES:
• At least 2 partners from 2 different member countries
• Funded under national funding schemes
• Market driven
Publ funding forR&D&I
ic 17

18. EUREKA
Funding schemes:
(1) individual projects
Open call (around 490 running projects)
(2) umbrellas
Thematic networks
EUROAGRI FOOD CHAIN (2009-2013)
(3) Clusters
Long-term, strategically significant industry initiatives
ACQUEAU (2010-2015)
(4) EUROSTARS
Publ funding forR&D&I
ic 18

19. EUREKA
Participation Duration Max budget Funding rate
At least 2 Not specified € 1,6 M According to
partners from 2 on average national rules
different
member
countries
Publ funding forR&D&I
ic 19

20. EUR A S
OST R
• Funding industrial research carried out by SME’s
• €400M of budget
• 2 calls of proposals yearly
• Any technological area
• New product, process or service
• Market perspective
• Leader: R&D-performing SME
• At least 50% of R&D work done by SMEs
• Funded under national schemes
Publ funding forR&D&I
ic 20

21. EUR A S
OST R
Participation Duration Budget Funding rate Upcoming
call
At least 2 partners Up to 36 Not specified According to Autumn
from 2 different months national rules 2012
member countries
On average: On average: On average: -- --
3 to 4 partners 29 months €1,4 M
Publ funding forR&D&I
ic 21

22. EUR A S
OST R
Examples:
Eurostars E!4258 ISTAR
Injection System for Transderm Administration of dRugs
Budget: 3580000 €
Led by: CROSSJECT Medical Technology (France)
E! 4731 Arrayvolution
A revolution in flexible cost-effective DNA and high density
microarray production
Budget: 1443500 €
Led by: FlexGen (The Netherlands)
Publ funding forR&D&I
ic 22

23. EEAGr nt
as
• „EEA structural funds”
• Key areas of support : environmental protection, climate
change, research and scholarships, civil society, health and
children, gender equality, justice and cultural heritage.
• 2009-14: €1.79 billion (Norway: 97%)
• Available for NGOs, research and academic institutions,
and the public and private sectors in the 12 newest EU
member states, Greece, Portugal and Spain.
• The funding backs programmes and projects in priority
areas agreed with each country.
Publ funding forR&D&I
ic 23

24. EEAGr nt
as
http://www.eeagrants.org
Publ funding forR&D&I
ic 24

25. Isr el bil t a coop.
a i aer l
Sellected calls:
Czech Republic-Israel Industrial R&D
Cooperation Framework (Dec2012?)
Russia-Israel Call for Proposals (10
Sept)
Countries involved:
Czech Republic, Denmark, Finland,
France, Germany, Greece, Hungary,
Italy, Lithuania, Poland, Romania,
Russia, Spain, Sweden, Switzerland,
Turkey, UK
Publ funding forR&D&I
ic 25

26. cal caenda
ls l r
• 7th Framework Programme --> 2013 (to be published
mid-July)
• Eureka - ongoing
• Eurostars – Autumn 2012
• ERASME – 28th September 2012
• Celtic – 15th October 2012
• Israeli Industrial bilateral R&D Cooperation
Framework – September with Russia, Poland and
Czech Republic
If you want to stay tuned subscribe to our newsletter at:
www.exeq.eu
Publ funding forR&D&I
ic 26

27. food 4t
hought
• keep focus on your idea
• be market oriented
• team up with academics
• build up your research project portfolio
• money is not all you can get
• submit often, never give up
Publ funding forR&D&I
ic 27

28. quest
ions?
Publ funding forR&D&I
ic 28

29. howw ca hel
e n p…
• Research concept
• State of the art analysis
• Market research
• Concept adaptation
• Program search
• Project parter serach
• Standard consortium agreement
• Project budgeting
• Project plan and tasks
• Project application form filling out and submission
Publ funding forR&D&I
ic 29

30. …
• Project financial reporting
• Project merit reporting
• Project merit audit
• Project formal audit
• Project reporting training
• R&D projects funding possibilities training
• Project application preparation training
Publ funding forR&D&I
ic 30

31. cont ctme!
a
Exeq (a brand of Disruptive Concepts Sp. z o.o.)
ul. Willowa 2 lok. 1, 00-790 Warsaw, Poland
E-mail: jan.kaczmarek@exeq.eu
Find us on: www.exeq.eu
facebook.com/EXEQ.EU
@exeq_eu
linkedin.com/companies/exeq
Publ funding forR&D&I
ic 31